137 related articles for article (PubMed ID: 21925064)
1. Long-term effects of intermittent Iloprost infusion on pulmonary arterial pressure in connective tissue disease.
Caravita S; Wu SC; Secchi MB; Dadone V; Bencini C; Pierini S
Eur J Intern Med; 2011 Oct; 22(5):518-21. PubMed ID: 21925064
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of adenosine versus iloprost by acute vasodilator test in patients of pulmonary arterial hypertension complicated with connective tissue diseases].
Tian Z; Chen TB; Fang Q; Zeng XF; Liu YT; Li MT; Jiang XC; Gao P; Cheng KA; Wang Q
Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2099-102. PubMed ID: 20058611
[TBL] [Abstract][Full Text] [Related]
3. Acute and long-term effects of inhaled iloprost in portopulmonary hypertension.
Melgosa MT; Ricci GL; García-Pagan JC; Blanco I; Escribano P; Abraldes JG; Roca J; Bosch J; Barberà JA
Liver Transpl; 2010 Mar; 16(3):348-56. PubMed ID: 20209595
[TBL] [Abstract][Full Text] [Related]
4. Aerosolized iloprost in CREST syndrome related pulmonary hypertension.
Launay D; Hachulla E; Hatron PY; Goullard L; Onimus T; Robin S; Fauchais AL; Queyrel V; Michon-Pasturel U; Hebbar M; Saulnier F; Devulder B
J Rheumatol; 2001 Oct; 28(10):2252-6. PubMed ID: 11669165
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary capillary endothelial metabolic dysfunction: severity in pulmonary arterial hypertension related to connective tissue disease versus idiopathic pulmonary arterial hypertension.
Langleben D; Orfanos SE; Giovinazzo M; Hirsch A; Baron M; Senécal JL; Armaganidis A; Catravas JD
Arthritis Rheum; 2008 Apr; 58(4):1156-64. PubMed ID: 18383374
[TBL] [Abstract][Full Text] [Related]
6. Effects of nebulised iloprost on pulmonary function and gas exchange in severe pulmonary hypertension.
Reichenberger F; Mainwood A; Doughty N; Fineberg A; Morrell NW; Pepke-Zaba J
Respir Med; 2007 Feb; 101(2):217-22. PubMed ID: 16831539
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of iloprost for the treatment of ischaemic digits in paediatric connective tissue diseases.
Zulian F; Corona F; Gerloni V; Falcini F; Buoncompagni A; Scarazatti M; Martini G; Zacchello F
Rheumatology (Oxford); 2004 Feb; 43(2):229-33. PubMed ID: 12923288
[TBL] [Abstract][Full Text] [Related]
8. [The clinical analysis of pulmonary arterial hypertension in connective tissue disease].
Ji YQ; Zhang ZL; Lu WX
Zhonghua Nei Ke Za Zhi; 2006 Jun; 45(6):467-71. PubMed ID: 16831323
[TBL] [Abstract][Full Text] [Related]
9. [Clinical analysis of 79 pulmonary arterial hypertension cases from 1892 connective tissue disease patients].
Lei YX; Zhang X; Cui Y; Dong GF; Luo RQ
Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(41):2934-7. PubMed ID: 20137654
[TBL] [Abstract][Full Text] [Related]
10. The short-term role of corticosteroid therapy for pulmonary arterial hypertension associated with connective tissue diseases: report of five cases and a literature review.
Kato M; Kataoka H; Odani T; Fujieda Y; Otomo K; Oku K; Horita T; Yasuda S; Atsumi T; Ohira H; Tsujino I; Nishimura M; Koike T
Lupus; 2011 Oct; 20(10):1047-56. PubMed ID: 21676917
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of domiciliary intravenous iloprost in idiopathic and connective tissue disease-associated pulmonary arterial hypertension.
Ramjug S; Hussain N; Hurdman J; Elliot CA; Sabroe I; Armstrong IJ; Billings C; Hamilton N; Kiely DG; Condliffe R
Respirology; 2017 Feb; 22(2):372-377. PubMed ID: 27651181
[TBL] [Abstract][Full Text] [Related]
12. [The acute effects of inhaled iloprost on hemodynamics and oxygenation in chronic thromboembolic pulmonary hypertension].
Luo L; Yang YH; Cui N; Xie WM; Zhai ZG; Ma ZH; Wang C
Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2103-5. PubMed ID: 20058612
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the acute hemodynamic effects of inhaled nitroglycerin and iloprost in patients with pulmonary hypertension undergoing mitral valve surgery.
Yurtseven N; Karaca P; Uysal G; Ozkul V; Cimen S; Tuygun AK; Yuksek A; Canik S
Ann Thorac Cardiovasc Surg; 2006 Oct; 12(5):319-23. PubMed ID: 17095973
[TBL] [Abstract][Full Text] [Related]
14. Sildenafil for pulmonary arterial hypertension associated with connective tissue disease.
Badesch DB; Hill NS; Burgess G; Rubin LJ; Barst RJ; Galiè N; Simonneau G;
J Rheumatol; 2007 Dec; 34(12):2417-22. PubMed ID: 17985403
[TBL] [Abstract][Full Text] [Related]
15. Comparison between iloprost and alprostadil in the treatment of Raynaud's phenomenon.
Marasini B; Massarotti M; Bottasso B; Coppola R; Del Papa N; Maglione W; Comina DP; Maioli C
Scand J Rheumatol; 2004; 33(4):253-6. PubMed ID: 15370722
[TBL] [Abstract][Full Text] [Related]
16. The effect of intravenous iloprost on pulmonary artery hypertension after paediatric congenital heart surgery.
Onan IS; Ozturk E; Yildiz O; Altin HF; Odemis E; Erek E
Interact Cardiovasc Thorac Surg; 2016 Feb; 22(2):194-9. PubMed ID: 26604214
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the usage of intravenous iloprost and nitroglycerin for pulmonary hypertension during valvular heart surgery.
Baysal A; Bilsel S; Bulbul OG; Kayacioglu I; Idiz M; Yekeler I
Heart Surg Forum; 2006; 9(1):E536-42. PubMed ID: 16387672
[TBL] [Abstract][Full Text] [Related]
18. [Clinical analysis of pulmonary arterial hypertension secondary to connective tissue disease in children].
Xing Y; Song HM; Wu XY; He YY; Wei M
Zhonghua Er Ke Za Zhi; 2008 Nov; 46(11):822-6. PubMed ID: 19099898
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary arterial hypertension complicating connective tissue diseases.
Hassoun PM
Semin Respir Crit Care Med; 2009 Aug; 30(4):429-39. PubMed ID: 19634082
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and hemodynamic characteristics and possibilities for therapy in patients with severe (functional class IV) pulmonary arterial hypertension associated with diffuse connective tissue diseases].
Nikolaeva EV; Yudkina NN; Kurmukov IA; Novikova DS; Markelova EI; Volkov AV
Ter Arkh; 2015; 87(5):24-32. PubMed ID: 26155616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]